osteoclast
cell
uniqu
respons
dissolv
organ
inorgan
compon
bone
develop
part
bone
remodel
cycl
throughout
life
cell
origin
hematopoiet
precursor
monocytemacrophag
lineag
present
bone
marrow
peripher
circul
number
andor
activ
frequent
increas
wide
rang
clinic
disord
associ
excess
bone
loss
affect
million
peopl
osteoporosi
major
metabol
bone
diseas
predispos
patient
fractur
age
women
age
men
increas
bone
resorpt
due
increas
osteoclastogenesi
decreas
osteoclast
apoptosi
osteoclast
may
also
play
role
etiolog
posttraumat
osteoarthr
ptoa
common
form
arthriti
earli
stage
diseas
pathogenesi
phase
increas
bone
resorpt
turnov
periarticular
subchondr
bone
volum
increas
number
osteoclast
prior
later
stage
sclerosi
eburn
similarli
increas
osteoclast
function
activ
directli
respons
gener
bone
loss
occur
rheumatoid
arthriti
thu
hypothes
antiresorpt
strategi
select
target
osteoclast
andor
carri
activ
drug
osteoclast
cell
directli
would
highli
desir
therapeut
treat
bone
diseas
involv
upregul
osteoclast
activ
osteoclast
cell
express
rank
receptor
receptor
activ
nuclear
factor
kappa
b
effect
serv
ideal
molecular
target
rank
express
osteoclast
precursor
well
matur
osteoclast
rank
essenti
signal
receptor
osteoclast
differenti
process
osteoclastogenesi
trigger
osteoclast
differenti
factor
known
rankligand
rankl
rank
signal
addit
signal
cfm
receptor
macrophagecolonystimul
factor
mcsf
trigger
prolifer
fusion
mononuclear
cell
format
multinucl
matur
osteoclast
matur
osteoclast
also
express
calcitonin
receptor
upon
surfac
known
decad
promin
neg
control
bone
resorpt
calcitonin
receptor
g
proteincoupl
receptor
famili
compris
seven
transmembranespan
receptor
domain
whose
signal
inhibit
osteoclast
activ
vitro
vivo
calcitonin
receptor
activ
upon
osteoclast
ligand
calcitonin
rapidli
induc
loss
ruffl
border
immobl
follow
cell
retract
arrest
bone
resorpt
calcitonin
receptor
signal
also
alter
ion
transport
distribut
impair
enzym
activ
inhibit
osteoclastogen
effect
rankl
sinc
antibodi
exquisit
specif
target
recognit
thu
gener
highli
select
outcom
follow
system
administr
purpos
develop
univers
osteoclasttarget
platform
drugdeliveri
strategi
order
deliv
antiresorpt
drug
use
antirank
mab
capabl
local
cell
respons
bone
resorpt
chosen
salmon
calcitonin
model
drug
act
calcitonin
receptor
also
found
boneresorb
osteoclast
monoclon
antibodi
mab
rank
receptor
gener
use
hybridoma
technolog
previous
perform
laboratori
briefli
femal
balbc
mice
immun
intraperiton
three
time
recombin
human
srank
receptor
peprotech
usa
day
use
complet
incomplet
freund
adjuv
respect
antigen
day
use
phosphatebuff
salin
pb
ph
immun
respons
antigen
assess
measur
titer
polyclon
antibodi
mous
serum
use
indirect
enzymelink
immunosorb
assay
elisa
mice
highest
antibodi
titer
euthan
splenectom
day
final
inject
antigen
spleen
cell
fuse
myeloma
cell
ratio
use
wv
polyethylen
glycol
peg
sigma
usa
accord
techniqu
describ
previous
milstein
hybridoma
cell
suspend
cultur
medium
rpmi
supplement
penicillin
streptomycin
lglutamin
psg
hypoxanthin
aminopterin
thymidin
hat
fetal
bovin
serum
fb
sigma
usa
cell
seed
tissu
cultur
plate
incub
humidifi
carbon
dioxid
incub
week
clone
maintain
hat
medium
week
hybridoma
cell
line
screen
indirect
elisa
cell
line
produc
specif
antibodi
reclon
success
time
limit
dilut
ensur
monoclon
stabil
cell
line
hybridoma
cell
line
propag
larg
tissu
cultur
flask
condit
supernat
collect
purif
igg
mab
achiev
affin
chromatographi
use
protein
g
agaros
sigma
usa
igg
immunoglobulin
subclass
determin
use
mous
hybridoma
isotyp
reagent
accord
instruct
manufactur
sigma
usa
elisa
perform
flatbottom
plate
nuncimmuno
maxisorbtm
plate
nunc
antibodi
secret
hybridoma
cell
detect
indirect
elisa
briefli
antigen
human
srank
receptor
use
coat
concentr
overnight
well
wash
three
time
pb
ph
avoid
nonspecif
bind
incub
bsa
h
room
temperatur
wash
well
incub
supernat
hybridoma
clone
h
room
temperatur
wash
bound
antibodi
detect
use
secondari
goat
antimous
igg
conjug
horseradish
peroxidas
gamhrpo
dilut
h
room
temperatur
final
wash
tetramethylbenzidin
tmb
substrat
ad
well
incub
min
room
temperatur
optic
densiti
od
measur
nm
use
elisa
vmax
kinet
micropl
reader
molecular
devic
corp
california
usa
clone
show
elisa
valu
five
time
higher
neg
control
consid
posit
sera
unimmun
mice
irrelev
antibodi
use
neg
control
rpmi
media
posit
sera
hyperimmun
mice
use
blank
posit
control
respect
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
perform
purifi
antibodi
reduc
nonreduc
condit
antibodi
mix
load
buffer
run
polyacrylamid
gel
thiol
reagent
ad
load
buffer
reduc
condit
cleav
disulfid
bond
polypeptid
gel
stain
coomassi
blue
protein
band
detect
individu
heavi
light
chain
antibodi
elisa
perform
use
rank
receptor
coat
concentr
overnight
avoid
nonspecif
bind
well
incub
bsa
h
room
temperatur
wash
well
incub
differ
concentr
antibodi
h
well
wash
pb
bound
antibodi
detect
use
secondari
antibodi
goat
antimous
igg
conjug
horseradish
peroxidas
h
final
wash
tmb
substrat
ad
well
incub
min
optic
densiti
od
measur
nm
western
blot
analysi
rank
receptor
kda
electrophores
sdspage
use
acrylamid
gel
transfer
onto
nitrocellulos
membran
use
mini
transblot
apparatu
membran
block
skim
milk
pbst
h
wash
pbst
cut
strip
incub
purifi
mab
solut
h
wash
strip
react
gamhrpo
h
bind
mab
rank
receptor
detect
use
enhanc
chemiluminesc
neg
control
primari
antibodi
omit
antigen
strip
incub
pb
confirm
rank
receptor
target
potenti
gener
mab
vitro
osteoclastlik
cell
gener
lab
tek
ii
chamber
slide
system
nunc
raw
cell
describ
gener
osteoclast
osteoblastlik
cell
line
known
lack
rank
receptor
use
neg
control
likewis
osteoclast
cell
cultur
omit
primari
mab
also
use
method
neg
control
cell
cultur
wash
pb
fix
paraformaldehyd
pb
ph
min
rins
thoroughli
block
bsa
pb
h
cell
incub
antirank
mab
overnight
antibodi
detect
carri
use
rabbit
antimous
iggfitc
sigma
usa
min
visual
cell
nuclei
slide
counterstain
phenylindol
dapi
sigma
dilut
pb
cultur
slide
separ
chamber
mount
photograph
use
confoc
microscopi
zeiss
lsm
zen
softwar
microscop
order
gener
antirank
mabsalmon
calcitonin
conjug
mabsct
free
thiol
group
gener
antirank
mab
react
molar
excess
traut
reagent
room
temperatur
h
fig
traut
reagent
sigma
usa
cyclic
thioimid
compound
react
spontan
effici
primari
amin
ph
result
sulfhydryl
addit
free
sulfhydryl
moieti
found
present
igg
mab
determin
ellman
assay
gener
thiolreact
calcitonin
analogu
synthet
salmon
calcitonin
sct
calbiochem
usa
dmso
mgml
mix
nhspegmal
creativ
biochem
usa
dmso
mgml
sigma
usa
molar
ratio
dmso
chosen
reaction
medium
instabl
nh
sct
aqueou
solut
sct
highli
solubl
highli
stabl
dmso
reaction
primari
amin
sct
nh
group
nhspegmal
allow
proceed
room
temperatur
constant
stir
min
sct
three
primari
amin
residu
ly
ly
nterminu
react
nh
function
group
nhspegmal
gener
three
intermedi
conjug
mono
di
trisubstitut
thiol
reactiv
sct
analogu
fig
function
thiolreact
sct
analogu
ad
intermitt
constant
stir
thiolmab
solut
molar
ratio
reaction
thiolreact
mal
group
function
sct
sh
group
thiolmab
allow
proceed
room
temperatur
dark
constant
stir
h
unreact
sctpeg
remov
dialysi
fig
antirank
mabsct
conjug
examin
reduc
nonreduc
condit
sdspage
analysi
describ
elisa
perform
use
rank
receptor
coat
concentr
overnight
avoid
nonspecif
bind
well
incub
bsa
h
room
temperatur
well
incub
triplic
either
mab
alon
function
sctpeg
mabsct
conjug
h
well
wash
pbst
follow
incub
rabbit
antisalmon
calcitonin
antibodi
us
biolog
h
well
wash
pbst
three
time
incub
hrpo
conjug
goat
antirabbit
igg
r
system
h
final
wash
pbst
tmb
substrat
ad
well
od
measur
nm
osteoclastlik
cell
gener
cultur
raw
cell
transform
murin
monocyt
cell
line
purchas
american
type
cultur
collect
atcc
va
usa
raw
cell
cultur
confluenc
flask
gibco
high
glucos
dulbecco
modifi
eagl
medium
dmem
invitrogen
ca
usa
contain
gl
dglucos
lglutamin
mgl
sodium
pyruv
addit
heatinactiv
fetal
bovin
serum
fb
penicillinstreptomycin
ad
uml
invitrogen
usa
confluent
cell
harvest
scrape
centrifug
rpm
resuspend
ml
cultur
medium
number
cell
suspens
measur
use
brightlin
hemocytomet
hausser
scientif
pa
usa
seed
concentr
cultur
plate
corn
place
incub
overnight
allow
cell
attach
surfac
h
cultur
medium
replac
media
contain
ngml
macrophagecolonystimul
factor
mcsf
ngml
rankl
peprotech
nj
usa
osteoclast
success
gener
dose
mcsf
rankl
everi
h
cours
day
confirm
gener
multinucl
osteoclastlik
cell
cultur
cell
stain
enzym
tartrateresist
acid
phosphatas
trap
use
leukocyt
acid
phosphatas
trap
kit
sigmaaldrich
stloui
mo
usa
accord
manufactur
instruct
trapposit
multinucl
osteoclast
visual
light
microscopi
photograph
quantifi
total
trap
activ
vitro
osteoclast
cultur
cell
seed
concentr
cultur
plate
incub
h
peptid
factor
ngml
rankl
mcsf
ngml
ad
cultur
without
addit
nm
mab
nm
mabsct
nm
sct
medium
factor
replac
everi
h
osteoclastogenesi
assess
spectrophotometr
measur
trap
activ
day
briefli
medium
aspir
cell
monolay
wash
twice
pb
cell
lyse
triton
water
vv
min
trap
activ
cell
lysat
determin
use
acid
phosphatas
assay
kit
cayman
chemic
usa
assay
util
paranitrophenyl
phosphat
pnpp
chromogen
substrat
trap
enzym
first
step
acid
phosphatas
dephosphoryl
pnpp
ltartrat
inhibitor
nontartr
resist
acid
phosphatas
provid
kit
use
measur
trap
enzym
activ
second
step
phenol
oh
group
deproton
alkalin
condit
result
pnitrophenol
yield
intens
yellow
color
measur
nm
use
micropl
reader
quantifi
miner
resorpt
activ
osteoclastlik
cell
cultur
cell
suspend
cell
cultur
medium
seed
bd
bioscienc
slide
bd
bioscienc
usa
densiti
cellswel
incub
h
osteoclastlik
cell
success
gener
dose
ngml
rankl
ngml
mcsf
everi
h
cours
day
well
incub
nm
either
mab
alon
sct
alon
mabsct
conjug
half
volum
medium
factor
replac
everi
h
day
cultur
medium
aspir
slide
place
petridish
wash
doubledistil
water
remov
adher
cell
slide
soak
bleach
min
wash
doubledistil
water
slide
airdri
view
invert
light
microscop
low
power
imag
calcium
phosphat
miner
remain
slide
acquir
quantifi
resorpt
effect
osteoclast
imag
analyz
use
javabas
imageprocess
program
imagej
nih
usa
ensur
mabsct
conjug
cytotox
cell
osteoclast
employ
mtt
assay
mitochondri
dehydrogenas
viabl
cell
cleav
tetrazolium
ring
mtt
yield
purpl
formazan
crystal
increas
decreas
cell
number
result
concomit
chang
amount
formazan
form
indic
degre
cytotox
caus
test
materi
raw
cell
seed
plate
initi
densiti
cellswel
incub
h
cell
confluent
cultur
medium
replac
basic
dmem
media
without
fb
incub
min
cultur
medium
replac
basic
dmem
media
contain
nm
mab
mabsct
sct
respect
quadrupl
cell
incub
h
medium
replac
basic
medium
contain
tetrazolium
bromid
mtt
concentr
incub
h
remov
supernat
wash
twice
phosphatebuff
salin
newli
form
purpl
formazan
crystal
dissolv
solubil
solut
use
vitro
toxicolog
assay
kit
sigma
aldrich
st
loui
usa
absorb
measur
nm
use
micropl
reader
confirm
calcitonin
bioactiv
lost
conjug
mab
confirm
abil
mabsct
conjug
trigger
calcitonin
receptor
human
breast
cancer
cell
known
contain
calcitonin
receptor
use
previous
describ
briefli
cell
atcc
va
usa
cultur
triplic
cultur
medium
contain
penicillinstreptomycin
fetal
bovin
serum
insulin
iuml
cell
seed
plate
initi
densiti
cellswel
incub
air
day
cell
wash
hbss
preincub
cultur
medium
devoid
fb
insulin
antibiot
cell
dose
phosphodiesteras
inhibitor
ibmx
mm
incub
min
one
hundr
nm
mab
mab
sct
sct
ad
well
except
control
cell
treat
ibmx
plate
incub
min
remov
supernat
cell
wash
three
time
cold
phosphatebuff
salin
resuspend
cell
lysi
buffer
cell
frozen
thaw
gentl
mix
freezethaw
cycl
repeat
three
time
mixtur
centrifug
g
min
remov
cellular
debri
supernat
collect
store
camp
concentr
measur
use
cyclic
adenosin
monophosph
camp
enzym
immunoassay
eia
kit
r
system
usa
statist
analysi
conduct
use
graph
pad
prism
graphpad
softwar
inc
ca
result
present
mean
standard
deviat
three
sampl
unpair
ttest
use
assign
signific
group
pvalu
less
threshold
signific
twoway
anova
use
mtt
assay
band
kda
seen
unconjug
antirank
igg
separ
band
heavi
chain
kda
light
chain
kda
observ
reduc
condit
mabsct
conjug
band
kda
observ
confirm
conjug
taken
place
reduc
condit
sdspage
conjug
band
kda
kda
observ
suggest
conjug
pegyl
calcitonin
heavi
light
chain
antibodi
fig
optic
densiti
seen
linearli
increas
concentr
mab
fig
spectrophotometr
absorb
valu
antirank
antibodi
respect
elisa
carri
conjug
show
bind
conjug
antibodi
coat
rank
receptor
sct
attach
conjug
detect
use
anticalcitonin
antibodi
thu
confirm
intact
mabsct
conjug
optic
densiti
mab
alon
neglig
calcitonin
detect
anticalcitonin
antibodi
similarli
od
sctpeg
also
significantli
low
antirank
mab
target
moieti
necessari
bind
rank
coat
plate
fig
elisaderiv
spectrophotometr
absorb
valu
mab
sctpeg
mabsct
conjug
respect
recombin
human
srank
receptor
kda
polypeptid
electrophores
polyacrylamid
gel
transfer
nitrocellulos
membran
incub
gener
mab
band
detect
kda
chemiluminesc
detect
antirank
igg
fig
osteoclast
gener
dose
cell
rankl
mcsf
stain
trap
techniqu
commonli
use
visual
osteoclast
principl
behind
stain
trap
involv
use
napthol
phosphat
conjunct
fast
garnet
gbc
salt
detect
acid
phosphatas
diazonium
fast
garnet
gbc
salt
select
coupl
rapidli
acid
ph
form
insolubl
dye
deposit
napthol
asbi
releas
enzymat
hydrolysi
coupl
immedi
fast
garnet
gbc
salt
result
format
insolubl
maroon
deposit
site
activ
tartar
acid
use
order
demonstr
presenc
tartrateresist
acid
phosphatas
henc
cell
contain
tartratesensit
acid
phosphatas
devoid
activ
cell
contain
tartrat
acidresist
phosphatas
show
maroon
dye
deposit
site
activ
stain
confirm
presenc
trapposit
multinucl
osteoclastlik
cell
limit
well
dose
exogen
mcsf
rankl
cell
cultur
condit
describ
fig
confoc
microscopi
confirm
antirank
receptor
mab
stain
green
color
limit
surfac
receptor
present
osteoclast
precursor
well
matur
osteoclastlik
cell
fig
counterstain
dapi
blue
color
confirm
multinucl
phenotyp
osteoclastlik
giant
cell
nucleoli
also
wit
imag
demonstr
fluoresc
fluorescein
isothiocyan
fitc
stain
neg
control
slide
fig
c
commerci
avail
antirank
mab
use
posit
method
control
confirm
raw
osteoclast
precursor
well
matur
osteoclastlik
cell
inde
stain
surfac
rank
receptor
use
immunocytochemistri
raw
cell
cultur
treat
exogen
rankl
mcsf
show
increas
trap
activ
compar
control
without
cytokin
treatment
found
releas
osteoclastassoci
enzym
potent
inhibit
mabsct
conjug
unconjug
mab
alon
compar
sct
alon
fig
measur
decreas
trap
activ
treatment
mabsct
conjug
also
conjug
show
greater
inhibit
trap
compar
sct
treatment
alon
osteoclastlik
cell
gener
calcium
phosphateco
cultur
well
shown
capabl
resorb
immedi
calcium
phosphat
layer
surround
result
direct
contrast
precursor
raw
cell
cultur
absenc
mcsf
rankl
shown
affect
calcium
phosphat
coat
manner
osteoclastlik
cell
cultur
treat
mabsct
conjug
mab
alon
demonstr
signific
inhibitori
effect
resorpt
abil
osteoclastlik
cell
measur
conserv
calcium
phosphat
layer
slide
integr
densiti
valu
idv
remain
calcium
phosphat
layer
cultur
treat
mabsct
conjug
significantli
greater
treat
sct
alon
fig
test
potenti
cytotox
effect
mab
andor
mabsct
conjug
test
raw
cell
viabil
use
mtt
assay
antirank
monoclon
antibodi
mabsct
conjug
sct
show
demonstr
cytotox
concentr
test
nm
measur
absorb
formazan
solut
form
h
incub
fig
thu
viabil
cell
perturb
mab
andor
conjug
treatment
use
vitro
competit
bind
assay
camp
activ
determin
breast
cancer
cell
known
contain
calcitonin
receptor
assay
confirm
sct
mabsct
conjug
capabl
stimul
camp
product
bind
calcitonin
receptor
significantli
lower
absorb
valu
measur
due
competit
natur
assay
indic
abil
sct
andor
mabsct
gener
intracellular
camp
presenc
phosphodiesteras
inhibitor
convers
mabtreat
control
well
exhibit
neglig
intracellular
camp
gener
accordingli
high
absorb
valu
competit
bind
assay
observ
fig
osteoclast
cell
capabl
resorb
miner
bone
howev
current
antiresorpt
therapi
specif
target
osteoclast
cell
elicit
system
side
effect
cell
osteoclast
exampl
develop
duoden
ulcer
gastric
eros
potenti
even
osteonecrosi
jaw
catastroph
low
energi
fractur
femor
shaft
associ
differ
class
bisphosphon
commonli
prescrib
medic
osteoporosi
estrogen
hormon
replac
therapi
stimul
uterin
breast
tissu
predispos
patient
neoplast
diseas
leg
muscl
cramp
joint
ach
deep
vein
thrombosi
associ
select
estrogen
receptor
modul
therapi
similarli
convent
salmon
calcitonin
shown
limit
antiresorpt
efficaci
like
part
poor
bioavail
bone
cell
undesir
uptak
drug
calcitonin
receptor
present
tissu
bone
sinc
pharmacolog
arrest
osteoclast
mainstay
treat
system
bone
loss
drug
deliveri
strategi
target
osteoclast
directli
would
provid
potenti
therapeut
advantag
reduc
system
bone
loss
select
deliv
antiresorpt
drug
cargo
osteoclast
antibodi
renown
exquisit
specif
target
recognit
gener
highli
select
outcom
follow
system
administr
rank
receptor
predominantli
express
surfac
matur
osteoclast
hypothes
antirank
antibodi
would
facilit
effect
osteoclast
target
platform
deliveri
antiresorpt
drug
directli
resorb
bone
cell
salmon
calcitonin
singl
chain
polypeptid
hormon
consist
amino
acid
chosen
model
drug
studi
sct
therapi
known
inhibit
andor
slow
osteoclastmedi
resorpt
bone
loss
whilst
posit
influenc
osteoinduct
bone
format
henc
design
conjug
strategi
wherebi
calcitonin
would
coupl
antibodi
direct
predominantli
osteoclastspecif
receptor
order
impart
osteoclast
specif
attach
calcitonin
cargo
deliveri
sct
osteoclast
cell
virtu
antibodymedi
target
platform
would
ensur
calcitonin
drug
remain
primarili
local
bone
tissu
system
administr
would
directli
contrast
passiv
interact
calcitonin
tissu
express
calcitonin
receptor
kidney
liver
lung
spleen
heart
thyroid
henc
deliveri
system
capabl
improv
sct
target
local
osteoclast
could
potenti
posit
impact
sct
therapi
whilst
reduc
drug
concentr
nonbon
loci
contain
calcitonin
receptor
use
hybridoma
technolog
gener
character
specif
monoclon
antibodi
recombin
human
rank
receptor
chemic
coupl
synthet
sct
antirank
mab
carrier
pegyl
sct
process
conjug
use
polym
polyethylen
glycol
known
improv
major
disadvantag
convent
sct
increas
solubl
stabil
efficaci
reduc
immunogenec
also
establish
pegyl
enhanc
enzymat
stabil
calcitonin
proteolysi
form
effect
shield
degrad
enzym
whilst
improv
efficaci
vivo
increas
molecular
size
thu
contribut
reduc
renal
filtrat
allow
less
frequent
administr
synthes
bioconjug
initi
character
use
sdspage
analysi
elisa
protein
band
kda
observ
conjug
nonreduc
condit
sdspage
analysi
band
seen
kda
kda
reduc
condit
thu
suggest
conjug
pegyl
sct
mab
occur
elisa
verifi
success
conjug
sct
mab
anticalcitonin
secondari
antibodi
reagent
would
detect
immobil
calcitonin
residu
part
primari
antirank
conjug
bind
rankcoat
well
elisa
plate
slight
signal
observ
pegyl
sct
assum
could
due
reaction
thiol
reactiv
mal
function
group
pegyl
sct
free
thiol
group
bsa
use
block
agent
case
conjug
mal
group
util
reaction
free
thiol
group
gener
antibodi
order
verifi
efficaci
mabsct
conjug
employ
vitro
osteoclastlik
cell
cultur
well
establish
osteoclast
deriv
cell
monocytemacrophag
lineag
form
cellular
fusion
mononuclear
precursor
henc
util
raw
cell
line
differenti
vitro
osteoclastlik
cell
exposur
mcsf
rankl
cytokin
rankl
essenti
factor
necessari
osteoclast
differenti
whilst
mcsf
also
known
also
identifi
essenti
factor
necessari
initi
osteoclastogenesi
main
role
mcsf
act
surviv
factor
osteoclast
precursor
cell
induc
express
rank
receptor
stimul
rankl
immunocytochemistri
confirm
osteoclast
target
potenti
gener
antirank
mab
vitro
fluoresc
stain
antirank
mab
specif
local
cellular
surfac
receptor
dapi
stain
show
success
gener
multinucl
osteoclastlik
cell
demonstr
fitc
stain
seen
neg
control
result
support
evid
osteoclastlik
cell
gener
raw
precursor
cell
express
rank
receptor
gener
antirank
antibodi
use
potenti
osteoclast
target
platform
success
gener
osteoclastlik
cell
also
confirm
trap
stain
confirm
multinucl
cell
marooncolor
dye
deposit
due
presenc
trap
enzym
use
marker
osteoclast
function
year
determin
vitro
efficaci
antirank
mabsct
conjug
osteoclast
activ
quantifi
osteoclast
activ
use
spectrophotometr
total
cultur
trap
activ
assay
miner
resorpt
assay
trap
shown
specif
sensit
indic
bone
resorpt
contribut
intracellular
process
primari
bone
matrix
degrad
product
prior
final
releas
basolater
membran
resorb
osteoclast
cell
osteoclast
boneresorb
cell
bodi
show
abil
dissolv
miner
inorgan
phase
bone
matrix
known
hydroxyapatit
found
use
conjug
cultur
significantli
reduc
trap
enzym
activ
compar
sct
alon
use
mab
alon
also
show
inhibit
trap
enzym
activ
although
caus
effect
shown
antirank
antibodi
alon
test
specul
bind
rank
receptor
antibodi
may
function
receptor
antagonist
competit
bind
would
interfer
interact
rankl
rank
essenti
step
osteoclast
differenti
nonetheless
antiresorpt
andor
anabol
effector
function
could
attribut
develop
target
deliveri
strategi
osteoclast
cell
receptor
evalu
mabsct
conjug
effect
abil
osteoclast
resorb
bone
cultur
osteoclastlik
cell
calcium
phosphateco
cultur
plate
presenc
conjug
antibodi
sct
found
conjug
mab
alon
capabl
significantli
reduc
resorpt
miner
layer
compar
sct
alon
perform
cyclic
amp
assay
confirm
bioactiv
conjug
calcitonin
human
breast
carcinoma
cell
known
express
calcitonin
receptor
use
purpos
bind
sct
receptor
activ
adenylyl
cyclas
enzym
respons
gener
camp
vitro
camp
assay
result
confirm
modif
sct
conjug
interfer
abil
bind
calcitonin
receptor
trigger
biolog
activ
measur
conjug
increas
activ
calcitonin
alon
exact
reason
effect
still
clear
like
conjug
strategi
allow
one
mole
antibodi
becom
conjug
greater
one
mole
calcitonin
report
igg
treat
molar
excess
traut
reagent
thiol
group
gener
may
result
attach
pegyl
calcitonin
molecul
per
molecul
igg
result
obtain
far
quit
encourag
gener
antibodi
synthesi
vitro
evalu
conjug
conjug
antibodi
alon
show
good
efficaci
trap
activ
inhibit
resorpt
pit
assay
howev
camp
assay
show
conjug
serv
purpos
deliv
activ
drug
cargo
conjug
show
abil
bind
calcitonin
receptor
gener
intracellular
cyclic
amp
thu
show
advantag
antibodi
alon
advent
novel
ranklscaveng
antibodybas
antiresorpt
strategi
amgen
inc
may
prove
efficaci
target
rank
receptor
directli
antibodi
order
success
antagon
receptor
signal
osteoclast
function
howev
neither
scaveng
antagonist
motiv
antiresorpt
strategi
focu
target
deliveri
given
drug
cargo
antirank
mabconjug
design
would
function
univers
osteoclast
target
platform
one
potenti
limit
osteoclast
target
platform
remain
ranklrank
signal
entir
restrict
osteoclast
precursor
known
involv
regul
cell
type
studi
ranklrank
signal
control
develop
lactat
mammari
gland
pregnanc
highest
level
day
mice
sever
studi
look
transgen
rankl
rank
mice
found
complet
absenc
lymph
node
led
studi
involv
patient
osteoclastpoor
form
autosom
recess
osteopetrosi
aro
found
caus
diseas
variou
mutat
rankl
research
found
patient
show
palpabl
sign
lymph
node
strengthen
theori
ranklrank
signal
involv
lymph
node
format
human
rank
known
express
monocytemacrophag
dendrit
cell
special
immun
cell
program
captur
process
antigen
bodi
present
tcell
howev
target
drug
cargo
rank
receptor
cell
may
necessarili
result
drug
action
cell
cargo
care
chosen
affect
cell
type
exampl
highli
unlik
cell
matur
osteoclast
express
rank
receptor
calcitonin
receptor
time
thu
boolean
andor
logic
appli
select
differenti
cargo
target
cellular
phenotyp
express
rank
receptor
given
time
extent
limit
remain
fulli
determin
howev
necessarili
preclud
explor
rank
receptor
target
strategi
may
turn
provid
comprehens
understand
rank
signal
crosstalk
signal
pathway
studi
detail
gener
antibodymedi
osteoclasttarget
platform
drugdeliveri
strategi
may
find
util
univers
osteoclasttarget
platform
order
directli
target
deliv
antiresorpt
agent
antiinflammatori
agent
cathepsin
k
inhibitor
disintegrin
hatpas
inhibitor
directli
osteoclast
cell
shown
platform
capabl
employ
antiresorpt
strategi
effort
center
vivo
evalu
target
strategi
